Septerna (SEPN) Assets Average (2024 - 2026)
Septerna's quarterly Assets Average came in at $582.9 million in Q1 2026, up 30.91% year-on-year from $445.3 million in Q1 2025, and down 3.07% quarter-over-quarter from $601.4 million in Q4 2025.
Septerna has reported Assets Average for 3 years, with the latest figure at $582.9 million in Q1 2026.
- For the quarter ending Q1 2026, Assets Average rose 30.91% year-over-year to $582.9 million; the trailing twelve-month figure through Mar 2026 stood at $582.9 million (up 30.91% YoY), and the FY2025 full-year result was $526.4 million, up 79.21% from the prior year.
- Assets Average for Q1 2026 stood at $582.9 million, down from $601.4 million in the prior quarter.
- The five-year high for Assets Average was $601.4 million in Q4 2025, with the low at $315.4 million in Q4 2024.
- Average Assets Average over 3 years is $480.1 million, with a median of $478.1 million recorded in 2025.
- Year-over-year, Assets Average soared 90.67% in 2025 and soared 30.91% in 2026.
- Tracing SEPN's Assets Average over 3 years: stood at $315.4 million in 2024, then soared by 90.67% to $601.4 million in 2025, then retreated by 3.07% to $582.9 million in 2026.
- The last three Assets Average figures came in at $582.9 million (Q1 2026), $601.4 million (Q4 2025), and $510.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 13.04 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 33.42 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 1.72 Bn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 331.70 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 40.89 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 26.06 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 26.03 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 40.71 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 5.05 Bn |
| 10 | Septerna | 1.34 Bn | 1.34 Bn | - | 582.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 582.94 Mn |
| Dec 31, 2025 | 601.42 Mn |
| Sep 30, 2025 | 510.94 Mn |
| Jun 30, 2025 | 424.63 Mn |
| Mar 31, 2025 | 445.29 Mn |
| Dec 31, 2024 | 315.42 Mn |